Cargando…
External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
The United Kingdom‐Primary Biliary Cholangitis (UK‐PBC) risk scores are a set of prognostic models that estimate the risk of end‐stage liver disease in patients with PBC at 5‐, 10‐ and 15‐year intervals. They have not been externally validated outside the United Kingdom. In this retrospective, exter...
Autores principales: | Cheung, Angela C., Gulamhusein, Aliya F., Juran, Brian D., Schlicht, Erik M., McCauley, Bryan M., de Andrade, Mariza, Atkinson, Elizabeth J., Lazaridis, Konstantinos N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983113/ https://www.ncbi.nlm.nih.gov/pubmed/29881819 http://dx.doi.org/10.1002/hep4.1186 |
Ejemplares similares
-
Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019) -
Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis
por: Ali, Ahmad Hassan, et al.
Publicado: (2021) -
Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)